Federal Register Notice: FDA is reestablishing the Medical Imaging Drugs Advisory Committee in CDER’s Division of Advisory Committee and Consultants Management. The committee reviews and evaluates data on the safety and effectiveness of marketed and investigational human drug products for use in diagnostic and therapeutic procedures using radioactive pharmaceuticals and contrast media used in diagnostic radiology. To view this notice, click here.
